Complete tumour elimination, especially in patients with late-stage metastatic lesions, requires the recruitment of an antigen-dependent immune response through collaboration between CD4+/CD8+ T cells and B cells, as well as the production of cytokines. The gene discussed is CD8A; the disease is neoplasm.